| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $166.31M | $103.92M | $93.87M | $66.33M | $93.85M |
| R&D | $117.67M | $65.30M | $52.12M | $36.17M | $34.79M |
| SG&A | $48.64M | $38.62M | $41.74M | $30.16M | $59.06M |
| Operating Income | -$166.31M | -$103.92M | -$93.87M | -$66.33M | -$93.85M |
| Interest Expense | $5.48M | $2.28M | $700.00K | – | – |
| Tax Expense | $0.00 | – | – | – | -$1.16M |
| Net Income | -$183.79M | -$108.68M | -$95.73M | -$56.80M | -$93.04M |
| EPS (basic) | -2.0600 | -1.5400 | -2.4400 | -1.8400 | -3.4000 |
| EPS (diluted) | -2.0600 | -1.5400 | -2.4400 | -1.8400 | -3.4000 |
| Shares (diluted) | $89.33M | $70.46M | $39.16M | $30.86M | $27.38M |